The association between iliocostal distance and the number of vertebral and non-vertebral fractures in women and men registered in the Canadian Database For Osteoporosis and Osteopenia (CANDOO)

Olszynski, WP; Ioannidis, G; Sebaldt, RJ; Hanley, DA; Petrie, A; Brown, JP; Josse, RG; Murray, TM; Goldsmith, CH; Stephenson, GF; Papaioannou, A; Adachi, JD

doi:10.1186/1471-2474-3-22

Table 3 Univariate parameter coefficient estimates and P-values for the association between risk factors and the number of vertebral and non-vertebral fractures in women

From: The association between iliocostal distance and the number of vertebral and non-vertebral fractures in women and men registered in the Canadian Database For Osteoporosis and Osteopenia (CANDOO)

	No. Vertebral fractures		No. Non-Vertebral Fractures
	Coefficient	P-value	Coefficient	P-value
Age	0.034	<0.001	0.018	<0.001
Height	-0.012	0.083	0.004	0.454
Weight	-0.001	0.768	0.002	0.534
Iliocostal distance	-0.271	<0.001	-0.115	<0.001
Menopausal status	0.516	0.003	0.305	0.015
Age at menopause	0.001	0.917	-0.006	0.405
Lumbar spine BMD	-0.813	0.048	-0.722	0.026
Femoral neck BMD	-3.069	<0.001	-1.901	<0.001
Trochanter BMD	-3.381	<0.001	-2.415	<0.001
Ward's triangle BMD	-2.928	<0.001	-1.951	<0.001
Prevalent vertebral fractures	NA		0.310	0.002
Prevalent non-vertebral fractures	0.391	0.003	NA
Currently smoking	0.018	0.759	0.049	0.258
Family history of fracture	-0.158	0.305	0.121	0.272
Alcohol-beverages/week	-0.013	0.529	-0.012	0.435
No. of falls	-0.004	0.935	0.079	0.017
Calcium intake	-0.000	0.499	0.000	0.536
Exercise	-0.000	0.248	-0.000	0.895
Etidronate use	0.315	0.003	0.188	0.014
Alendronate use	0.250	0.009	0.062	0.366
Fluoride use	0.392	0.541	0.843	0.067
Raloxifene use	-0.053	0.807	0.167	0.280
Hormone replacement use	-0.069	0.551	-0.001	0.992
Corticosteroids use	0.113	0.308	-0.046	0.564
Calcium supplement use	0.302	0.006	0.107	0.171
Vitamin D supplement use	0.147	0.115	0.094	0.163
Lung disease^a	0.223	0.264	0.334	0.020
Liver disease^b	-0.068	0.866	-0.143	0.621
Thyroid disease^c	-0.185	0.318	0.060	0.656
Cancer^d	0.327	0.400	0.190	0.495
Visual impairment	0.136	0.526	0.174	0.258
Osteoporosis	-0.109	0.409	0.002	0.982
Inflammatory bowel disease	-0.634	0.091	0.618	0.022
Epilepsy	1.047	0.054	-0.175	0.656
Coronary disease	0.582	0.164	0.401	0.174
Cerebrovascular disease	1.042	0.002	1.016	<0.001
Rheumatoid arthritis	0.083	0.898	0.403	0.383
Diabetes	0.157	0.648	0.241	0.328
Kidney failure	0.115	0.700	0.200	0.352

* BMD= bone mineral density, NA= not available. ^a Lung disease includes asthma, chronic bronchitis and other lung diseases. ^b Liver disease includes cirrhosis, hepatitis and cholangitis. ^c Thyroid disease includes hyper, hypo, nodule, and other. ^d Cancer includes breast, ovaries, cervix, uterus and colon.

Back to article page

ISSN: 1471-2474

Contact us

Submission enquiries: bmcmusculoskeletaldisorders@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Musculoskeletal Disorders

Contact us